ClinChoice acquires CSI to expand its footprint in Southeast Asia
CSI is a clinical CRO that provides cost-effective clinical solutions through its team of experienced clinical research professionals…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Jan 24
CSI is a clinical CRO that provides cost-effective clinical solutions through its team of experienced clinical research professionals…
12 Jan 24
Under the partnership, ElevateBio BaseCamp scientists will gain access to Xcellbio’s Avatar incubator system for cell therapy research…
12 Jan 24
Developed using Elicio’s lymph node targeting Amphiphile technology, ELI-002 is a structurally investigational therapeutic immunotherapy designed to target…
12 Jan 24
The partnership is intended to develop a suite of AI models to generate synthetically accessible biologically active compounds…
12 Jan 24
Illumina Ventures Labs is well positioned to enable early-stage companies to accelerate the time needed to reach their…
12 Jan 24
Approach leverages novel mechanisms such as remyelination and anti-neuroinflammation to address a broad spectrum of degenerative CNS diseases
11 Jan 24
WuXi Biologics will grant exclusive rights to the investigational monoclonal antibodies to BioNTech in exchange for an upfront…
11 Jan 24
Under the alliance, Japanese Foundation for Cancer Research will become a valued member of Parexel's Global Site Alliance…
11 Jan 24
XeriJect formulations are innovative, ready-to-use, viscoelastic pharmaceutical suspensions that have the potential to improve drug delivery, lower treatment…
11 Jan 24
Collaboration Aims to Improve Patient Experience, Accessibility and Efficiency in Decentralized Clinical Trials